These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 31053135)

  • 1. Qualitative and quantitative research of medication review and drug-related problems in Hungarian community pharmacies: a pilot study.
    Szilvay A; Somogyi O; Meskó A; Zelkó R; Hankó B
    BMC Health Serv Res; 2019 May; 19(1):282. PubMed ID: 31053135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication review in German community pharmacies - Post-hoc analysis of documented drug-related problems and subsequent interventions in the ATHINA-project.
    Seidling HM; Send AFJ; Bittmann J; Renner K; Dewald B; Lange D; Bruckner T; Haefeli WE
    Res Social Adm Pharm; 2017 Nov; 13(6):1127-1134. PubMed ID: 27816566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical evaluation of the drug-related problem management process in Swiss community pharmacies.
    Krähenbühl JM; Kremer B; Guignard B; Bugnon O
    Pharm World Sci; 2008 Dec; 30(6):777-86. PubMed ID: 18392732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of interaction risks of patients with polypharmacy and the pharmacist interventions performed to solve them-A multicenter descriptive study according to medication reviews in Hungarian community pharmacies.
    Szilvay A; Somogyi O; Dobszay A; Meskó A; Zelkó R; Hankó B
    PLoS One; 2021; 16(6):e0253645. PubMed ID: 34157039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studying the impact of a medication use evaluation by the community pharmacist (Simenon): Drug-related problems and associated variables.
    Wuyts J; Maesschalck J; De Wulf I; Lelubre M; Foubert K; De Vriese C; Boussery K; Goderis G; De Lepeleire J; Foulon V
    Res Social Adm Pharm; 2020 Aug; 16(8):1100-1110. PubMed ID: 31759887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacists' performance of clinical interventions during adherence support medication reviews.
    Hatah E; Tordoff J; Duffull SB; Braund R
    Res Social Adm Pharm; 2014; 10(1):185-94. PubMed ID: 23688540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacists' role in handling problems with prescriptions for antithrombotic medication in Belgian community pharmacies.
    Desmaele S; De Wulf I; Dupont AG; Steurbaut S
    Int J Clin Pharm; 2015 Aug; 37(4):656-68. PubMed ID: 25822042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of drug-related problems identified by community pharmacies.
    Hämmerlein A; Griese N; Schulz M
    Ann Pharmacother; 2007 Nov; 41(11):1825-32. PubMed ID: 17925500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an enhanced service for medication review with follow up in Swiss community pharmacies: Pre-post study protocol.
    Amador-Fernández N; Escaith M; Simi E; Quintana-Bárcena P; Berger J
    PLoS One; 2023; 18(10):e0292037. PubMed ID: 37847695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands.
    Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG
    Int J Clin Pharm; 2016 Feb; 38(1):46-53. PubMed ID: 26597955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of community pharmacists in providing clinical medication reviews.
    Laaksonen R; Duggan C; Bates I
    Ann Pharmacother; 2010; 44(7-8):1181-90. PubMed ID: 20571102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristic of drug-related problems and pharmacists' interventions in a stroke unit in Thailand.
    Semcharoen K; Supornpun S; Nathisuwan S; Kongwatcharapong J
    Int J Clin Pharm; 2019 Aug; 41(4):880-887. PubMed ID: 31054061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-related problems identified during medication review before and after the introduction of a clinical decision support system.
    Verdoorn S; Kwint HF; Hoogland P; Gussekloo J; Bouvy ML
    J Clin Pharm Ther; 2018 Apr; 43(2):224-231. PubMed ID: 28971492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical care research and education project: pharmacists' interventions.
    Kassam R; Farris KB; Burback L; Volume CI; Cox CE; Cave A
    J Am Pharm Assoc (Wash); 2001; 41(3):401-10. PubMed ID: 11372905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collaboration between hospital and community pharmacists to address drug-related problems: The HomeCoMe-program.
    Ensing HT; Koster ES; Dubero DJ; van Dooren AA; Bouvy ML
    Res Social Adm Pharm; 2019 Mar; 15(3):267-278. PubMed ID: 29773308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Audit of community pharmacists' prescribing interventions: Quality assessment of a newly reimbursed service.
    MacKeigan LD; Dolovich L; Petrovic B; MacCallum L; Bojarski EA; Pojskic N
    J Am Pharm Assoc (2003); 2018; 58(6):622-629. PubMed ID: 30190200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using the costs of drug therapy to screen patients for a community pharmacy-based medication review program.
    Krähenbühl JM; Decollogny A; Bugnon O
    Pharm World Sci; 2008 Dec; 30(6):816-22. PubMed ID: 18551382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of drug-related problems followed by clinical pharmacist interventions in an outpatient pharmacotherapy clinic.
    Shahrami B; Sefidani Forough A; Najmeddin F; Hadidi E; Toomaj S; Javadi MR; Gholami K; Sadeghi K
    J Clin Pharm Ther; 2022 Jul; 47(7):964-972. PubMed ID: 35218217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DOCUMENT: a system for classifying drug-related problems in community pharmacy.
    Williams M; Peterson GM; Tenni PC; Bindoff IK; Stafford AC
    Int J Clin Pharm; 2012 Feb; 34(1):43-52. PubMed ID: 22101425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of drug-related problems with new prescriptions using a modified PCNE classification system.
    Eichenberger PM; Lampert ML; Kahmann IV; van Mil JW; Hersberger KE
    Pharm World Sci; 2010 Jun; 32(3):362-72. PubMed ID: 20229029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.